First Report of an Extensively Drug-Resistant VIM-2 Metallo-β-Lactamase-Producing Brevundimonas diminuta Clinical Isolate

Author:

Almuzara Marisa N.1,Barberis Claudia M.1,Rodríguez Carlos H.1,Famiglietti Angela M. R.1,Ramirez Maria S.2,Vay Carlos A.1

Affiliation:

1. Laboratorio de Bacteriología, Instituto de Fisiopatología y Bioquímica Clínica, Hospital de Clínicas José de San Martín, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina

2. Instituto de Microbiología y Parasitología Médica, Universidad de Buenos Aires-Consejo Nacional de Investigaciones Científicas y Tecnológicas (IMPaM, UBA-CONICET), Facultad de Medicina, Buenos Aires, Argentina

Abstract

ABSTRACT In the literature, only three Brevundimonas diminuta environmental isolates carrying metallo-β-lactamase genes were recently published. However, so far, no B. diminuta clinical isolates carrying these carbapenem resistance genes have been described. Here we report the first VIM-2 metallo-β-lactamase-producing B. diminuta clinical isolate obtained from an immunocompromised patient.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Reference15 articles.

1. VIM-2-producing Pseudomonas putida, Buenos Aires;Almuzara MN;Emerg. Infect. Dis.,2007

2. First Case of Human Infection Due to Pseudomonas fulva , an Environmental Bacterium Isolated from Cerebrospinal Fluid

3. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; M100-S18 18th informational supplement. Clinical and Laboratory Standards Institute Wayne PA.

4. Brevundimonas diminuta infections and its resistance to fluoroquinolones;Han XY;J. Antimicrob. Chemother.,2005

5. Evaluation of the Hodge Test and the Imipenem-EDTA Double-Disk Synergy Test for Differentiating Metallo-β-Lactamase-Producing Isolates of Pseudomonas spp. and Acinetobacter spp

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3